Search research articles
Contact Us
Filters
Showing results (51-60 of 59) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 59 results.
Immunity & Ageing : I & A
|
December 16, 2023
The inter-link of ageing, cancer and immunity: findings from real-world retrospective study
Xiaomin Fu, Peng Qin, Fanghui Li, et al.
Frontiers in Oncology
|
September 26, 2022
Sintilimab maintenance therapy post first-line cytokine-induced killer cells plus chemotherapy for extensive-stage small cell lung cancer
Baozhen Ma, Yu Zhou, Yiman Shang, et al.
Journal of Hematology & Oncology
|
February 5, 2016
Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer
Zibing Wang, Yuqing Liu, Rui'e Li, et al.
Scientific Reports
|
May 20, 2025
The baseline circulating immunophenotype characteristics associate with PD(L)-1 targeted treatment response, irae onset, and prognosis
Xiaomin Fu, Fanghui Li, Hongqin You, et al.
Cancer Immunology, Immunotherapy : CII
|
July 30, 2022
Association of hepatitis B virus DNA levels with overall survival for advanced hepatitis B virus-related hepatocellular carcinoma under immune checkpoint inhibitor therapy
Mengchao An, Wenkang Wang, Jie Zhang, et al.
Frontiers in Immunology
|
January 21, 2022
High Complete Response Rate in Patients With Metastatic Renal Cell Carcinoma Receiving Autologous Cytokine-Induced Killer Cell Therapy Plus Anti-Programmed Death-1 Agent: A Single-Center Study
Lingdi Zhao, Tiepeng Li, Yongping Song, et al.
Frontiers in Immunology
|
August 1, 2022
Combination of Low-Dose Gemcitabine and PD-1 Inhibitors for Treatment in Patients With Advanced Malignancies
Hao Huang, Ling Peng, Bicheng Zhang, et al.
Frontiers in Immunology
|
December 23, 2021
The Sequence of Chemotherapy and Toripalimab Might Influence the Efficacy of Neoadjuvant Chemoimmunotherapy in Locally Advanced Esophageal Squamous Cell Cancer-A Phase II Study
Wenqun Xing, Lingdi Zhao, Yan Zheng, et al.
Cancer Research
|
January 7, 2021
T Cells Expanded from PD-1<sup>+</sup> Peripheral Blood Lymphocytes Share More Clones with Paired Tumor-Infiltrating Lymphocytes
Tiepeng Li, Lingdi Zhao, Yonghao Yang, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 59) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 59 results.
Immunity & Ageing : I & A
|
December 16, 2023
The inter-link of ageing, cancer and immunity: findings from real-world retrospective study
Xiaomin Fu, Peng Qin, Fanghui Li, et al.
Frontiers in Oncology
|
September 26, 2022
Sintilimab maintenance therapy post first-line cytokine-induced killer cells plus chemotherapy for extensive-stage small cell lung cancer
Baozhen Ma, Yu Zhou, Yiman Shang, et al.
Journal of Hematology & Oncology
|
February 5, 2016
Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer
Zibing Wang, Yuqing Liu, Rui'e Li, et al.
Scientific Reports
|
May 20, 2025
The baseline circulating immunophenotype characteristics associate with PD(L)-1 targeted treatment response, irae onset, and prognosis
Xiaomin Fu, Fanghui Li, Hongqin You, et al.
Cancer Immunology, Immunotherapy : CII
|
July 30, 2022
Association of hepatitis B virus DNA levels with overall survival for advanced hepatitis B virus-related hepatocellular carcinoma under immune checkpoint inhibitor therapy
Mengchao An, Wenkang Wang, Jie Zhang, et al.
Frontiers in Immunology
|
January 21, 2022
High Complete Response Rate in Patients With Metastatic Renal Cell Carcinoma Receiving Autologous Cytokine-Induced Killer Cell Therapy Plus Anti-Programmed Death-1 Agent: A Single-Center Study
Lingdi Zhao, Tiepeng Li, Yongping Song, et al.
Frontiers in Immunology
|
August 1, 2022
Combination of Low-Dose Gemcitabine and PD-1 Inhibitors for Treatment in Patients With Advanced Malignancies
Hao Huang, Ling Peng, Bicheng Zhang, et al.
Frontiers in Immunology
|
December 23, 2021
The Sequence of Chemotherapy and Toripalimab Might Influence the Efficacy of Neoadjuvant Chemoimmunotherapy in Locally Advanced Esophageal Squamous Cell Cancer-A Phase II Study
Wenqun Xing, Lingdi Zhao, Yan Zheng, et al.
Cancer Research
|
January 7, 2021
T Cells Expanded from PD-1<sup>+</sup> Peripheral Blood Lymphocytes Share More Clones with Paired Tumor-Infiltrating Lymphocytes
Tiepeng Li, Lingdi Zhao, Yonghao Yang, et al.
Page
of 6